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by 
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ABSTRACT 
 
 Cognitive impairment among older adults with type 2 diabetes may worsen health 
outcomes via negative impact on compliance with medical self-care recommendations.  
Results of several previous studies indicate that cognitive deficits are present in older 
European American adults with type 2 diabetes under some conditions, particularly 
related to glucose dysregulation (as evidenced by high glycated hemoglobin, i.e., 
HbA1c).  Despite the fact African Americans are disproportionately affected by diabetes 
and suffer significantly greater numbers of complications and more severe 
complications relative to European Americans, no published studies have examined 
cognitive functioning among older African American adults with type 2 diabetes.  
Further, markers of systemic inflammation have been associated with cognitive 
impairment in several conditions, but this relationship has not been examined in older 
adults with type 2 diabetes.  The purpose of the present study was to determine 
 whether: 1) cognitive deficits are present in older African American adults with type 2 
diabetes, and whether the deficits are related to 2) glucose dysregulation and 3) 
systemic inflammation.   
Several cognitive domains, including verbal memory and executive functions, 
were assessed in 71 African Americans with type 2 diabetes who ranged from 60 to 80 
years of age.  Exclusionary criteria included dementia, depression, neurological 
disease, or brain injury.  Also measured were HbA1c and two markers of systemic 
inflammation: C-reactive protein (CRP) and interleukin-6 (IL-6).  Results showed that 
higher HbA1c was significantly associated with poorer performance on several 
measures of executive function and verbal memory measures that tap executive 
function.  Higher IL-6 was significantly associated with slower motor function and higher 
semantic fluency.  Higher CRP was significantly associated with improved performance 
on measures of phonemic fluency, psychomotor speed and mental flexibility/working 
memory, and fine motor dexterity, but only for those with extremely high levels of CRP; 
when those participants were removed from the analyses, CRP was inversely related to 
cognitive performance.   
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CHAPTER 1:  INTRODUCTION 
Memory impairment is the most common cognitive complaint among individuals 
who present for neuropsychological evaluation (Butters, Soety, & Glisky, 1998).  The 
prospect of memory loss is cause for concern, given the potential for significant 
negative impact on many aspects of daily functioning and reduced quality of life 
(Perlmutter et al., 1987).  One medical group that may be particularly impacted by 
cognitive impairment is older adults with type 2 diabetes, because outcomes in diabetes 
depend largely on the patient’s consistent self-management of the condition.  Given the 
potential for cognitive problems to interfere with attempts to self-manage medical 
problems and follow a physician’s recommendations, cognitive deficits among older 
adults with diabetes could lead to further declines in health (Sinclair, Girling, & Bayer, 
2000).  In one longitudinal study of older adults with diabetes, even performance in the 
low average range on a cognitive screening measure was associated with a 20% 
increased risk of death 2 years later (McGuire, Ford, & Ajani, 2006). 
Diabetes is a disorder in which the body does not produce or does not properly 
utilize insulin, which is a hormone used in the metabolism of sugars, starches, and other 
foods.  Absence or impairment of insulin functioning in the body results in high levels of 
glucose in the blood and urine (hyperglycemia); these increases are paralleled by 
increases in brain extracellular glucose levels (McNay, McCarty, & Gold, 2001).  
Diabetes has more than one known etiology, the most common of which are referred to 
as type 1 and type 2 diabetes.  Type 1 diabetes is secondary to a failure of insulin 
production, and is usually diagnosed prior to age 30.  In contrast, type 2 diabetes results 
from the development of resistance to insulin, and is typically acquired in middle age or 
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later.  Type 2 diabetes is the most common form of the disorder, representing at least 
90% of the diabetes diagnoses in the U.S. (Laakso, 2003). Having diabetes increases 
the risk of many serious complications, including cardiovascular disease, retinopathy, 
neuropathy, and nephropathy.  Cognitive deficits are associated with both type 1 and 
type 2 diabetes, although they are observed less consistently in type 1 than in type 2 
diabetics (Ryan & Geckle, 2000b).   
Literature Review 
Predictors of Cognitive Decline.  Cognitive deficits are more likely to be found 
among older than younger individuals with type 2 diabetes (for reviews see: Awad, 
Gagnon, & Messier, 2004; Ryan & Geckle, 2000b).  Although cognitive deficits have 
been found in some studies in which middle-aged and elderly type 2 diabetics were 
combined into a single group (Elias, Elias, D'Agostino, Silbershatz, & Wolf, 1997; 
Gradman, Laws, Thompson, & Reaven, 1993; Perlmuter et al., 1984; Reaven, 
Thompson, Nahum, & Haskins, 1990; Vanhanen et al., 1997; Worrall, Moulton, & 
Briffett, 1993), studies comparing cognitive functions in middle-aged individuals with 
type 2 diabetes to those of age-matched controls yield no group differences (Mattlar, 
Falck, Rèonnemaa, & Hyyppèa, 1985; Zaslavsky, Gross, Chaves, & Machado, 1995).  
Such results suggest that combining older and middle-aged adults with type 2 diabetes 
into a single group might reduce the ability to detect group differences in cognitive 
performance relative to nondiabetic controls (Lowe, Tranel, Wallace, & Welty, 1994; 
Scott, Kritz-Silverstein, Barrett-Connor, & Wiederholt, 1998).  The evidence suggests 
that restricting the age range of a sample to older adults will maximize chances of 
detecting impaired cognitive functioning in adults with type 2 diabetes.    
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Acute and chronic glucose levels appear to be critical determinants of cognitive 
functioning among adults with type 2 diabetes.  Experimental manipulation of acute 
glycemic levels reveals a significant association with cognitive performance among both 
middle aged and older type 2 diabetics.  For instance, Greenwood, Kaplan, 
Hebblethwaite, and Jenkins (2003) tested a small group of middle-aged and older type 
2 diabetes patients with varying levels of blood glucose, allowing them to serve as their 
own controls.  Under hyperglycemic conditions only, a relative decline in delayed recall 
performance was observed on both a modified serial list learning task and an auditory-
verbal paragraph recall task.  In addition, older prediabetic patients with higher plasma 
glucose levels show changes in cognitive function similar to those seen in elderly type 2 
diabetics (U'Ren, Riddle, Lezak, & Bennington-Davis, 1990; Vanhanen et al., 1997).  
Furthermore, in some cases acute administration of glucose impairs memory in healthy 
adults (Craft, Murphy, & Wemstrom, 1994).   
Chronic glucose levels also appear to be associated with cognitive deficits in type 
2 diabetes.  Glycemic control is a medical term that refers to average blood glucose 
levels over time in a person with diabetes.  One measure of glycemic control is glycated 
hemoglobin.  Hemoglobin is the compound in red blood cells that transports oxygen, 
and the most common form of hemoglobin is called hemoglobin A.  Glucose binds to 
hemoglobin A, forming glycated hemoglobin.  Glycated hemoglobin is commonly 
designated as HbA1c and is elevated when plasma glucose levels are high.  The 
decomposition of glycated hemoglobin is slow and the buildup of glycated hemoglobin 
lasts between 1 and 4 months.  HbA1c reflects mean glucose levels over the past 2 
weeks to 3 months (American Diabetes Association, 2006; Garg, Sharp, & Stutts, 
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2006).  ADA guidelines indicate that  normal HbA1c is less than 6.0% (~120 mg/dL), 
while an HbA1c value greater than 7.0% (~150 mg/dL) represents poor glycemic control 
(American Diabetes Association, 2006). Several studies have shown an inverse 
relationship between HbA1c and verbal memory in older adults with type 2 diabetes 
(Gradman et al., 1993; Jagusch, Cramon, Renner, & Hepp, 1992; Perlmuter et al., 
1984; Reaven et al., 1990), although a few have found no such relationship (Lowe et al., 
1994; Zaslavsky et al., 1995). 
Longer duration of diabetes also predicts poorer cognitive performance in both 
elderly and middle-aged adults with type 2 diabetes (Cosway, Strachan, Dougall, Frier, 
& Deary, 2001; Dey, Misra, Desai, Mahapatra, & Padma, 1997; Elias et al., 1997; Gregg 
et al., 2000; Grodstein, Chen, Wilson, & Manson, 2001).  Longer duration of poor 
glycemic control may result in irreversible cognitive deficits (Awad, Gagnon, & Messier, 
2004).  Such duration-related cognitive changes are hypothesized to be due to 
prolonged hyperinsulinemia causing or contributing to the development of vascular 
disease.  Hypoglycemic medications appear to significantly ameliorate cognitive 
performance regardless of the duration of diabetes (Grodstein, Chen, Wilson, & 
Manson, 2001), however, which suggests that glucose levels may exert a more 
powerful influence on cognitive functioning than the putative structural changes that 
occur over a prolonged course of diabetes.      
Depression may also contribute to cognitive deficits among older patients with 
type 2 diabetes, because depression is independently associated with poorer cognitive 
functioning (Lezak, 1995).  Increased levels of depression often co-occur with significant 
medical conditions (Wells, Golding, & Burnam, 1988).  A recent meta-analysis 
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concluded that the presence of diabetes more than doubles the odds of depression 
(Anderson, Freedland, Clouse, & Lustman, 2001).  In some studies, controlling for 
depression attenuated the degree of verbal memory deficits observed in older adults 
with type 2 diabetes (Lindeman et al., 2001; Scott et al., 1998; Tun, Perlmuter, Russo, & 
Nathan, 1987).  In contrast, in other studies cognitive differences remained after 
controlling for depression (Gregg et al., 2000; Perlmuter et al., 1984; Vanhanen et al., 
1997).  Although it remains unclear why depression is a significant predictor in some 
studies and not others, it is obviously important to include this variable in any study of 
diabetes and cognitive function.  
Type 2 diabetes is associated with an increased risk of cardiovascular disease 
and thus stroke and vascular dementias (Harati, 1996).  The findings of one prospective 
study indicate that diabetics are significantly more likely than nondiabetics to develop 
dementia (Ott et al., 1999).  In another study there were no group differences in verbal 
memory after excluding individuals who had been diagnosed with dementia from their 
study of elderly diabetic patients and matched controls (Vanhanen et al., 1999).  A 
recent review examined a number of studies of cognitive functioning in older adults with 
type 2 diabetes, and concluded that a significant proportion of the variance in verbal 
memory could be accounted for by comorbid dementing processes (Awad, et al., 2004).  
Some studies have excluded older adult diabetics with dementia, however, and still 
found cognitive deficits (Mooradian, Perryman, Fitten, Kavonian, & Morley, 1988; 
Vanhanen et al., 1997).  These latter findings suggest that dementia is not the sole 
cause of cognitive deficits among older type 2 diabetics.  
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Diabetes is a cardiovascular risk factor.  Other cardiovascular risk factors that 
have been associated with cognitive deficits include obesity (Gunstad, Paul, Cohen, 
Tate, & Gordon, 2006; Kuo et al., 2005), hypercholesterolemia (Kivipelto et al., 2001), 
cigarette smoking (Hill, Nilsson, Nyberg, & Backman, 2003; Kalmijn, van Boxtel, 
Verschuren, Jolles, & Launer, 2002), and hypertension (Kuo et al., 2005; Vicario, 
Martinez, Baretto, Diaz Casale, & Nicolosi, 2005; Waldstein, Brown, Maier, & Katzel, 
2005).  Although antihypertensive drugs appear to be protective against dementia 
(Forette et al., 1998), they do not improve cognitive function in older, non-demented 
adults with moderate hypertension (Prince, Bird, Blizard, & Mann, 1996).  These latter 
findings suggest that hypertension can negatively impact cognition through means other 
than contributing to the development of vascular dementias.   
Inflammation may also contribute to cognitive deficits associated with type 2 
diabetes.  Inflammation occurs as part of the body’s nonspecific immune response.  
Nonspecific immunity is believed to be the body’s first line of defense against infection 
or injury because it is faster than a specific immune response (Maier & Watkins, 1998).  
A specific immune response involves the development of antibodies meant to fight 
specific foreign substances that enter the body, and may take several hours or days to 
develop.  In contrast, a nonspecific immune response can be seen within as little as 1 
hour after a foreign substance enters the body.  The nonspecific immune response 
includes activity by phagocytes (“eating cells”) that recognize and respond quickly to 
foreign substances and injured tissue in the body.  Responses include killing and 
interfering with the growth of foreign cells, and releasing proinflammatory proteins called 
cytokines.  These cytokines initiate a local inflammatory response and attract other 
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immune cells, which can help heal the injured area (Maier & Watkins, 1998).  There are 
also anti-inflammatory cytokines that act to dampen the immune response (O'Brien, 
Scott, & Dinan, 2004).  In addition to their local effects, proinflammatory cytokines also 
produce a more global bodily response to the infection or injury called the acute-phase 
response.  This involves a number of physiological adjustments including fever, and 
sickness behavior, a collection of behaviors, including reduced activity, hypersomnia or 
hyposomnia, and anorexia (Maier & Watkins, 1998; Reichenberg et al., 2001).  It is 
believed that these responses to infection and injury have evolved as adaptive 
strategies to help the body conserve resources in order to best combat infection and 
heal.  When the inflammatory response continues for an extended duration, however, 
risk of other illnesses and problems may increase.   
There is a link between inflammation and diabetes.  For instance, hyperglycemic 
crisis is associated with an increase in proinflammatory cytokines and other peripheral 
markers of inflammation (Stentz, Umpierrez, Cuervo, & Kitabchi, 2004).  Inflammation is 
also associated with impaired glucose regulation (Barzilay et al., 2001; Temelkova-
Kurktschiev, Henkel, Koehler, Karrei, & Hanefeld, 2002) and appears to precede and 
predict the development of diabetes (Barzilay et al., 2001; Duncan et al., 2003; 
Pradhan, Manson, Rifai, Buring, & Ridker, 2001; Schmidt et al., 1999; Spranger et al., 
2003).  For instance, high levels of the inflammatory markers c-reactive protein (CRP) 
and interleukin-6 (IL-6) are associated with an increased risk of developing type 2 
diabetes (Pradhan, Manson, Rifai, Buring, & Ridker, 2001).  Importantly, increases in 
peripheral levels of these markers can impair the functioning of the central nervous 
system (Wilson, Finch, & Cohen, 2002).  
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Inflammation can impair cognition.  High levels of the inflammatory markers CRP 
and IL-6 are associated with accelerated cognitive decline in healthy older adults 
(Engelhart et al., 2004; Teunissen et al., 2003; Weaver et al., 2002; Yaffe et al., 2003) 
and in older adults with metabolic syndrome (Yaffe et al., 2004).  Metabolic syndrome is 
a cluster of several commonly occurring disorders, including impaired glucose 
regulation.  Metabolic syndrome is diagnosed in the presence of three or more of the 
following:  elevated waist circumference (> 40” in men; > 35” in women), elevated serum 
triglycerides (> 150 mg/dL), reduced HDL cholesterol (< 40 mg/dL in men; < 50 mg/dL in 
women), hypertension (> 130/85 Hg), or elevated fasting glucose (> 100 mg/dL).  Older 
adults with metabolic syndrome and high inflammation are at increased risk for cognitive 
decline, whereas those with metabolic syndrome and low inflammation are not (Yaffe et 
al., 2004).  These latter findings in particular suggest that inflammation impacts 
cognition.  This interpretation is supported by research in rodents showing that 
increases in neural levels of proinflammatory cytokines, particularly in the hippocampus, 
impair memory (Brennan, Beck, & Servatius, 2004; Gemma, Fister, Hudson, & Bickford, 
2005; Maher, Nolan, & Lynch, 2005; Samuelsson, Jennische, Hansson, & Holmang, 
2006).  Moreover, decreasing brain levels of proinflammatory cytokines can reverse 
memory deficits (Balschun et al., 2004; Gemma et al., 2005).  To date there have been 
no studies specifically examining the association between inflammation and cognition in 
type 2 diabetes.   
Diabetes and Cognition.  Older adults with type 2 diabetes appear to have 
impairments in verbal memory (Elias et al., 1997; Gradman et al., 1993; Greenwood et 
al., 2003; Lucas et al., 2005; Mooradian et al., 1988; Perlmuter et al., 1984; Perlmuter, 
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Tun, Sizer, McGlinchey, & Nathan, 1987; Reaven et al., 1990; Vanhanen et al., 1997).  
In studies examining verbal memory abilities in this population, the measures employed 
to assess verbal declarative memory typically consisted of standardized or experimental 
versions of word list learning tasks or paragraph recall tests.  Findings include: 1) 
decrements in the number or percentage of list words recalled relative to age-matched 
nondiabetic controls (Mooradian et al., 1988; Perlmuter et al., 1984; Perlmuter et al., 
1987; Reaven et al., 1990; Vanhanen et al., 1997), 2) increased risk of impaired 
immediate and delayed memory on a paragraph recall task related to duration of 
diagnosis (Elias, Elias, D'Agostino, Silbershatz, & Wolf, 1997), and 3) a relative decline 
in delayed recall performance on both a serial list-learning task and an auditory-verbal 
paragraph recall task under experimentally induced hyperglycemic conditions 
(Greenwood et al., 2003).  Among middle-aged and older non-diabetic individuals with 
impaired glucose tolerance, there is a significant association between verbal memory 
deficits on a paragraph recall task and hippocampal atrophy, independent of age and 
score on a dementia screening measure (Convit, Wolf, Tarshish, & de Leon, 2003).  
This suggests a strong positive relationship between hippocampal integrity and verbal 
declarative memory performance in this population.   
Although the primary cognitive deficit among older adults with type 2 diabetes is 
typically purported to involve verbal declarative memory, there are compelling reasons 
to suspect that deficits in executive functioning may play a more critical role.  Executive 
functions include the ability to think abstractly and to plan, initiate, sequence, monitor, 
and inhibit complex, goal-directed behavior (DSM-IV; American Psychiatric Association, 
1994).  Relative to other cognitive abilities, executive functions appear to be 
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disproportionately affected by cardiovascular risk factors and disease.  Executive 
dysfunction has been linked to hypertension in older adults (Vicario, Martinez, Baretto, 
Diaz Casale, & Nicolosi, 2005), and is associated with acute elevations in blood 
pressure in otherwise healthy older adults (Kuo et al., 2004).   Furthermore, in a study of 
older adult African Americans, a summary cardiovascular risk score was associated 
with impairment in executive functions, but not in other cognitive skills, such as episodic 
memory or visuospatial function (Pugh, Kiely, Milberg, & Lipsitz, 2003).  Given that 
diabetes is a cardiovascular risk factor, in the absence of any other information it would 
be reasonable to hypothesize that the primary cognitive deficit associated with type 2 
diabetes is executive.    
It is possible that, in some instances, a result that is interpreted as showing a 
verbal memory deficit actually reflects a problem with executive functions.  The most 
common ways to assess verbal learning and memory are paragraph recall tasks such 
as the Logical Memory subtest from the Wechsler Memory Scale, and word list learning 
tasks like the California Verbal Learning Test (CVLT).  Initial correlational research 
indicated that the two tests were highly related (Delis, Cullum, Butters, & Cairns, 1988), 
and might be used interchangeably.  Subsequent studies, however, have revealed 
critical differences between the two tasks.  For example, compared to healthy controls, 
adults with executive dysfunction are impaired on CVLT-II but not on Logical Memory 
(Brooks, Weaver, & Scialfa, 2006; Tremont, Halpert, Javorsky, & Stern, 2000).  In fact, 
the CVLT measures a combination of verbal learning and memory, conceptual ability, 
and strategic organization (Lezak, 1995), and requires intact executive functions for 
adequate performance.  A recent review study (Awad et al., 2004) revealed that adults 
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with type 2 diabetes are more commonly impaired on “noncontextual” word list learning 
tasks, which require examinees to structure the information, than on paragraph 
recall/contextual tasks, in which the information is provided to examinees in a structured 
format.  Thus, interpreting poor performance on the CVLT as being indicative of a verbal 
memory deficit could be misleading.   
The CVLT consists of a 16-item word list which is read aloud several times, 
followed each time by a free recall trial and, after 20 minutes, a delayed free recall trial.  
Each of the 16 words on the list belongs to one of four semantic categories (e.g., fruits, 
herbs and spices, articles of clothing, and tools).  The ability to detect and make use of 
categories to facilitate performance is a common feature of tasks designed to measure 
the integrity of executive functions.  Optimal CVLT performance is obtained when the 
semantic categories of the words are noticed and used spontaneously to organize list 
words during encoding and to facilitate later recall (Alexander, Stuss, & Fansabedian, 
2003; Gershberg & Shimamura, 1995).  A failure of subjective organization as a 
learning and recall strategy may result in significant reductions in the number or 
percentage of list words freely recalled.  Previous studies of older adults with type 2 
diabetes using word list learning tasks typically reported only the total number or 
percentage of words recalled across all learning trials (Perlmuter et al., 1987; Reaven et 
al., 1990).  When such data are presented in isolation, the source of the cognitive deficit 
is ambiguous, and could reflect deficits other than verbal memory.  Consequently, it is 
impossible to determine whether an executive deficit contributed to a poor performance 
on this measure without examining other CVLT performance indicators, such as 
subjective strategy use.  The semantic clustering score provides a measure of one 
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particularly effective type of strategy an examinee could employ in order to facilitate the 
encoding and subsequent retrieval of list words.  The CVLT-II, a revised version of the 
CVLT released in 2000, includes several changes, including a larger normative sample, 
improved word lists, and revised scoring methods for the semantic clustering indices to 
adjust for chance levels of semantic clustering during word recall.       
The relationship between type 2 diabetes and executive functions is inconsistent.  
Poor performance on measures of executive function has been found in some studies of 
adults with type 2 diabetes (Elias et al., 1997; Gregg et al., 2000; Perlmuter et al., 1984; 
Reaven, Thompson, Nahum, & Haskins, 1990; Vanhanen et al., 1999), but not in others 
(Gradman et al., 1993; Greenwood et al., 2003; U'Ren et al., 1990).  Group differences 
between adults with type 2 diabetes and controls have been observed on several 
different measures of executive function, including:  Trail Making Test, part B (Gregg et 
al., 2000; Reaven et al., 1990; Vanhanen et al., 1999), Stroop Interference (Ryan & 
Geckle, 2000a), Phonemic Fluency (Hewer, Mussell, Rist, Kulzer, & Bergis, 2003; Lowe 
et al., 1994), Semantic Fluency (Kanaya, Barrett-Connor, Gildengorin, & Yaffe, 2004), 
and Wisconsin Card Sorting Test (WCST; Reaven, Thompson, Nahum, & Haskins, 
1990). Symbol Digit Modalities Test (SDMT) is a measure of processing speed and 
working memory.  SDMT (written version) did not differentiate adults with and without 
diabetes (U'Ren, Riddle, Lezak, & Bennington-Davis, 1990).  Given that adults with type 
2 diabetes purportedly have verbal memory deficits, any difficulties on SDMT may 
become more apparent when the oral version is administered.   
Using neuropsychological tests to isolate distinct executive deficits can be 
difficult because all neuropsychological tests categorized as executive function 
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measures require multiple executive functions (Daniels, Toth, & Jacoby, 2006).  In 
addition, the executive functions attributed to various measures vary across authors and 
studies, and may change depending on the age groups and participant populations in a 
given study.  Thus, different outcomes on these tests do not clarify which executive 
functions might be impaired by diabetes.  Nonetheless, aside from WCST, a common 
thread that may underlie the majority of executive tasks on which group differences 
between adults with and without type 2 diabetes have been detected is working 
memory. In fact, there is evidence linking CVLT performance and working memory.  In 
one study, two CVLT factors—general verbal learning and working memory—along with 
Trails B and Digit Span were significantly correlated with a canonical variable that 
accounted for 29% of the variance in the data (Vanderploeg, Schinka, & Retzlaff, 1994).  
In PET studies of healthy participants engaged in encoding word lists with varying 
demands for semantic organization, use of semantic organization strategies was 
associated with increased regional cerebral blood flow (rCBF) in dorsolateral prefrontal 
cortex (DLPFC; Fletcher, Shallice, & Dolan, 1998; Savage et al., 2001).  Several 
imaging studies indicate that DLPFC activation is associated with conditions that require 
monitoring, manipulating and/or updating the contents of working memory (Blumenfeld 
& Ranganath, 2006; Gerton et al., 2004; Staresina & Davachi, 2006; Volle et al., 2005).   
Diabetes and African Americans.  Surprisingly, there do not appear to be any 
comprehensive studies of cognitive function in African-American elders with type 2 
diabetes.  Compared to Americans of European descent, African Americans are 
disproportionately affected with type 2 diabetes (Brancati, Kao, Folsom, Watson, & 
Szklo, 2000; Harris et al., 1998; Robbins, Vaccarino, Zhang, & Kasl, 2000).  Failure to 
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take medication because of forgetting to do so is a significant predictor of poor glycemic 
control in African Americans (Hill-Briggs et al., 2005), indicating that cognitive deficits 
may have a strong impact on health in this population.  Importantly, the effects of type 2 
diabetes on cognition may be moderated by ethnicity.  For example, although cognitive 
deficits are found in older adult European Americans with type 2 diabetes, none were 
found in elderly Native Americans with type 2 diabetes once the effects of depression 
were removed (Lowe, Tranel, Wallace, & Welty, 1994).  Contrary to expectations based 
on studies of older adult Caucasians, one study of 43 African American participants 
aged 43-82 years (M = 59) showed that higher levels of HbA1c predicted improved 
performance on a measure of attention, and was marginally associated with better 
executive functions (Izquierdo-Porrera & Waldstein, 2002).  The fact that middle aged 
participants were included and that only 19% of the participants (N = 9) had self-
reported diabetes diagnoses, however, make it difficult to draw any strong conclusions 
from this study about the relationship between cognition and diabetes in African 
Americans.  A study employing a larger sample of older adult African Americans with 
physician-confirmed diagnoses of type 2 diabetes and which excludes middle aged 
participants would help to clarify the relationship between cognition and diabetes in this 
population.   
Present Study.  The purpose of the present study was to determine whether: 1) 
cognitive deficits are present in older African American adults with type 2 diabetes, and 
whether they are related to 2) glucose dysregulation and 3) inflammation.  An additional 
aim of the present study was to obtain a more comprehensive analysis of executive 
functions in older adults with Type 2 diabetes, and to determine whether CVLT-II 
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subjective organization in the form of semantic clustering is impaired in this population.  
To address these objectives, this study compared scores of older adults with type 2 
diabetes with published normative data on measures of cognitive function that included 
multiple measures of verbal declarative memory and of executive function.  
Subsequently, participants’ cognitive test scores, HbA1c levels (an indicator of glucose 
regulation), and levels of CRP and IL-6 (two markers of inflammation) were analyzed 
statistically in order to identify any relationships between cognitive performance, 
glucose regulation, and inflammation.  CRP and IL-6 were selected as the two markers 
of inflammation because of extensive evidence linking these markers with cognitive 
deficits (Engelhart et al., 2004; Schmidt et al., 2002; Samuelsson et al., 2006; 
Teunissen et al., 2003; Weaver et al., 2002; Yaffe et al., 2004; Yaffe et al., 2003).  
Specifically, higher levels of IL-6 and CRP have been associated with increased rates of 
cognitive decline (Yaffe et al., 2003) and dementia (Engelhart et al., 2004; Schmidt et 
al., 2002) in healthy older adults, and in older adults with metabolic syndrome (Dik et al., 
2007; Yaffe et al., 2004).  Higher baseline plasma IL-6 in a large sample of nondisabled 
elderly people was associated with an increased risk of cognitive decline at a 7-year 
follow-up (Weaver et al., 2002).  In a sample of healthy elderly people, higher CRP 
levels at baseline were associated with a decline in performance on a word list learning 
task over a 6-year follow-up period (Teunissen et al., 2003).   
Hypotheses and Predictions.  The first hypothesis was that older African-
American adults with uncontrolled type 2 diabetes would have cognitive deficits, 
particularly in verbal declarative memory and executive functions.  It was predicted 
that participants with type 2 diabetes would score significantly below the mean for 
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healthy controls in published normative data on CVLT-II measures of immediate and 
delayed recall and semantic clustering.  In addition, it was expected that participants 
with type 2 diabetes would perform significantly below average according to published 
norms for healthy controls on measures of executive function tapping working memory, 
including: Trail Making Test Part B, Stroop Color-Word, Phonemic and Semantic 
Fluency, and Symbol Digit Modalities Test.  It was also predicted that participants with 
type 2 diabetes would perform in the normal range according to published normative 
data for healthy control participants on measures of memory that are less dependent on 
executive functions (i.e., paragraph recall), and on other cognitive measures (e.g., 
simple attention, visuospatial judgment, fine motor dexterity).   
The second and third hypotheses were that cognitive deficits would be 
significantly predicted by glucose dysregulation (high HbA1c) and inflammation 
(elevated levels of the pro-inflammatory markers CRP and IL-6).  It was predicted 
that participants with 1) high HbA1c and/or 2) high CRP and IL-6 levels would score 
significantly lower than participants with normal levels of HbA1c and/or normal CRP and 
IL-6 levels on CVLT-II immediate and delayed recall and semantic clustering, and on 
measures of executive function, including: Trail Making Test Part B, Stroop Color-Word, 
Phonemic and Semantic Fluency, and Symbol Digit Modalities Test.  It was also 
predicted that HbA1c and the inflammation markers would not predict performance on 
measures of memory that are less dependent on executive functions (i.e., paragraph 
recall), or on other cognitive measures (e.g., simple attention, visuospatial judgment, 
fine motor dexterity).   
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CHAPTER 2:  METHOD 
Participants 
Potential participants were identified via a database of patient records at the 
Diabetes Clinic at Grady Memorial Hospital.  Individuals with a diagnosis of type 2 
diabetes who met other demographic criteria for the study were contacted by phone and 
invited to participate in the study.  Those individuals who expressed interest in the study 
were asked a series of screening questions in order to verify their suitability for the 
study.   Exclusionary criteria included: 1) history of head injury or major neurological 
disorder (including cerebral vascular accident and recent myocardial infarction), 2) 
current clinically significant levels of depression or anxiety, or history of other major 
psychiatric disorder, 3) significant and uncorrected sensory deficits (e.g., vision, 
hearing), and 3) current or previous history of substance abuse, including alcohol.  
Alcohol abuse was defined as two or more drinks per day in women, and three or more 
drinks per day in men.  In addition, given that estrogen replacement therapy in women 
affects cognition in differing ways depending on factors such as timing of therapy 
initiation (MacLennan et al., 2006) and comorbid medical conditions (Grady et al., 2002; 
MacLennan et al., 2006), female participants recruited for the study were not on 
estrogen replacement therapy.  Individuals who met criteria and agreed to participate in 
the study were instructed that on the day of their appointment for testing they were to 
take their normally prescribed medications and to bring along their glasses and/or 
hearing aids.   
 Of the 85 participants enrolled in the study, 14 participants were excluded from 
or discontinued testing.  Reasons for being excluded from testing included:  Impaired 
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performance on measures screening for dementia (n = 3) or depression (n = 4), 
reported history of excluded neurological conditions (n = 4), significant sensory 
impairments (n = 3).  In addition, one participant discontinued testing for undisclosed 
reasons.  Patients excluded from the study based on dementia and depression 
screenings were referred for psychiatric or neurological examinations.  The remaining 
71 participants were African American adults (62 females and 9 males) who ranged in 
age from 60 to 80 years (M = 67.01; SD = 5.0).   
Measures 
Medical variables that were measured included weight, blood pressure, 
abdominal circumference, and serum levels of HbA1c, CRP, and IL-6. The 
neuropsychological tests that were administered are commonly used, standardized 
measures of intellectual and cognitive functioning.  A listing and description of the 
measures follows.  Although several of the tests tap more than one cognitive domain, in 
the following list each test was assigned to a single cognitive domain. 
Mood Assessment.  The Geriatric Depression Scale (GDS; Yesavage et al., 
1982) consists of 30 statements about the examinee’s current/recent feelings and 
behaviors which are read aloud to the participant.  The examinee responds with “yes” or 
“no” to each statement.   
Cognitive Screening.  The Modified Mini-Mental State Examination (3MS; Teng & 
Chui, 1987) is a screening test for memory problems and dementia. This measure 
probes abilities across a number of areas, including orientation (e.g., to self, time, date, 
place), memory, attention and calculation, spoken and written language, and the ability 
to copy and remember named objects.  Clock Drawing (Spreen & Strauss, 1998) is a 
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screening test that assesses cognitive or visuospatial impairment.  The examinee draws 
a clock, including the numbers and the hands at a time designated by the examiner.  
Estimated IQ.  The North American Adult Reading Test (NAART; Blair & Spreen, 
1989) is a reading test consisting of 61 irregularly spelled words that examinees read 
aloud.  Accuracy of pronunciation of list words is used to estimate verbal IQ.  NAART 
and years of education can be used in a formula to predict a WAIS-R Vocabulary score 
(Uttl, 2002). 
Attention.  The Digit Span (DS) subtest from the Wechsler Memory Scale-Third 
Edition (WMS-III; Wechsler, 1997) is a brief test of simple auditory attention and 
auditory-verbal working memory.  The examiner reads aloud increasingly long series of 
digits, and the examinee attempts to repeat back the digit strings in the same order 
(Digits Forward), or in reversed order (Digits Backward).   
Memory.  During the Logical Memory (LM) subtest of the WMS-III, the examiner 
reads aloud two short stories.  After each story, the examinee attempts to recall verbally 
as much of the story as possible.  Following a distraction-filled delay, the examinee 
verbally recalls the stories again.  The CVLT-II (Delis, Kramer, Kaplan, & Ober, 2000) 
assesses several aspects of verbal learning, organization, and memory.  Examinees are 
read a list of words and asked to recall them in a series of trials, and then again 
following a distraction-filled delay.  Recognition is also probed.   
Executive Functions.  The Trail Making Test (TMT; Reitan & Wolfson, 1985) is a 
timed measure of motor speed, visual attention, and working memory.  The examinee 
draws lines on a page connecting consecutive series of numbers (Trails A) or 
alternating numbers and letters (Trails B).  The Stroop Color and Word Test (SCWT; 
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Golden, 1978) is a timed measure of attention, mental speed, and mental control.  The 
examinee names the colors of squares printed on a page, reads words printed on a 
page (all are names of colors), and then names the color of the ink in which some words 
(which name different colors) are printed.  The Symbol Digit Modalities Test (SDMT; 
Smith, 1982) is a measure of mental speed, motor speed, visual scanning, and mental 
flexibility/working memory.  The examinee pairs specific numbers with given geometric 
figures under timed conditions.  The Controlled Oral Word Association Test (COWAT; 
Benton, Hamsher, & Sivan, 1994; Spreen & Strauss, 1998) is a set of tasks measuring 
speed and fluency of verbal thought processes.  Phonemic fluency tasks assess a 
person’s ability to rapidly produce words beginning with a given letter.  Semantic fluency 
tasks measure a person’s ability to rapidly produce words fitting into a particular 
semantic category (e.g., animals).   
Language.  The Boston Naming Test (BNT; Kaplan, Goodglass, & Weintraub, 
2001) assesses object naming ability through spontaneous responses and the need for 
various types of cueing.  The examinee views a series of 60 drawings of objects, and 
names each item aloud within a 20-second time frame.   
Visuospatial Skill.  Judgment of Line Orientation (JOLO; Benton, Sivan, 
Hamsher, Varney, & Spreen, 1994) is a measure of visuospatial judgment.  Initially the 
examinee is presented with an array of numbered lines arranged at varying angles.  
Subsequently the examinee must correctly identify by number the orientations of a 
series of line pairs presented in isolation from the array.   
Motor Skill.  The Grooved Pegboard Test (GPT; Lafayette Instrument Company, 
1997) is a timed measure of fine motor coordination consisting of a pegboard with 25 
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randomly positioned slots.  Pegs with a ridge along one side must be rotated to match 
the hole before they can be inserted.   
Procedure 
Testing took place in the Outpatient Research Unit of Grady Diabetes Clinic at 
Grady Memorial Hospital.  After the study was fully described and consent was 
obtained, participants were screened for depression and dementia.  Participants who 
passed the screenings underwent a battery of neuropsychological testing consisting of a 
series of paper and pencil tests, which lasted approximately 2 hours.  Following 
neuropsychological testing, several medical variables were measured, including blood 
pressure, abdominal circumference, and weight.  Body Mass Index (BMI) was 
calculated using the weight measurement obtained during the appointment and 
participants’ self-reported height.  Finally, a phlebotomist took a blood sample from the 
participant’s arm in order to measure serum levels of CRP, IL-6, and HbA1c.  
Participants were paid $30 for each complete session of neuropsychological testing.  
During the informed consent process, participants were informed that they had a right to 
discontinue participation in the study at any time.  They were also informed that 
participants who elected to stop participating in the study would receive a prorated 
amount of compensation at the rate of $10 per hour of completed testing.  Prior to the 
initiation of the study, IRB approval was obtained from both Georgia State University 
and Emory University.        
Data Analyses 
 All data were entered into SPSS, checked for accuracy, and screened for outliers 
and violations of the assumptions of relevant statistical tests.  One variable (IL-6) was 
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log transformed to reduce skewness.  Descriptive statistics, including means and 
standard deviations, were compiled for all demographic, biomedical, and 
neuropsychological measures.  As constraints on participant recruitment did not permit 
the recruitment of a control group, scores from measures of cognitive functioning were 
compared with demographically appropriate normative data for the general population, if 
available, and converted into standard scores.  Scores from several neuropsychological 
measures were then categorized to indicate the percentages of participants falling into 
specified z-score ranges.   
Mayo’s Older African American Normative Studies (MOAANS; Lucas et al., 2005) 
was the source of ethnically appropriate normative data grouped by age and education 
level for the following measures:  Stroop Test, Trail Making Test, Phonemic Fluency – 
CFL, Semantic Fluency – Animal Naming, and Boston Naming Test.  Normative data for 
Grooved Pegboard and Phonemic Fluency – FAS was grouped by ethnicity, sex, age, 
and education (Heaton, Miller, Taylor, & Grant, 2004).  Normative data for the CVLT-II 
was obtained via the CVLT-II scoring software, which controls for age and sex only; 
normative sample cell sizes were too small to adequately stratify the sample across 
education levels (Delis et al., 2000).  Normative data for WAIS-III Digit Span and WMS-
III Logical Memory were obtained from the WAIS-III/WMS-III/WIAT-III computer scoring 
software program (The Psychological Corporation, 2001), which includes demographic 
corrections for ethnicity, sex, age, and, education level.  Normative data for SDMT were 
obtained from the test manual (Smith, 1982), and corrects for age (to 78 years) and 
education (12 years or less or 13 years or more).  No normative data were available for 
the following measures:  Semantic Fluency – Boys Names, and a 15-item version of 
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Judgment of Line Orientation in which the odd items from either form H or form V were 
administered.           
 Predictions about the association between HbA1c, IL-6, and CRP and cognition 
were tested using a series of hierarchical multiple regression analyses.   Criterion 
variables were select raw scores from the administered neuropsychological measures.  
Due to their covariance with the criterion variables, age and reading level (NAART) 
were controlled for in all analyses by regressing these variables on the criterion variable 
at the first step.  Age and education are two of the strongest predictors of performance 
scores on measures of neuropsychological functioning.  In the current study, reading 
level was chosen as a proxy for education level in analyses because studies have 
shown that: 1) among African American elders, reading level falls significantly below 
that predicted by self-reported education level (O'Bryant et al., 2007), and 2) reading 
level appears to be related to aspects of the educational experience that are important 
for performance on cognitive tests across several domains (Manly, 2005). Predictor 
variables were added to all regression equations in the following order: 1) age and 
NAART score, 2) HbA1c, and 3) IL-6, and CRP.  Given that glucose regulation is a 
relatively robust predictor of cognitive performance across studies, HbA1c was entered 
alone in the second block, and the more exploratory predictor variables measuring 
inflammation (IL-6 and CRP) were entered together in the third step. Sets of hierarchical 
multiple regression analyses will be presented grouping test scores from measures of 1) 
executive function, and 2) verbal memory.  A third set of hierarchical multiple regression 
analyses consisted of scores from cognitive measures on which no significant effects of 
the independent variables were predicted.    
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CHAPTER 3:  RESULTS 
Descriptive Statistics  
Table 1 shows frequencies, means, standard deviations, and variances for 
demographic, biomedical, and psychological variables.  Participants were predominantly 
female (87.3%) and had 11.3 + 2.6 years of education (5 to 18 years).  Time since 
diagnosis of type 2 diabetes was obtained from the patient database, and was 
measured in years.  Duration of diabetes in this sample ranged from 1 to 47 years (M = 
14.84; S.D. = 9.28).  Means for BMI and abdominal circumference were well above 
recommended limits.  Adults are considered overweight with a BMI between 25 and 30, 
and are considered obese with a BMI over 30.  According to those guidelines, the BMI 
data for this sample indicates that 7.4% were of normal weight, 22.1% were overweight, 
and 70.6% were obese.  National Heart Lung and Blood Institute guidelines state that 
abdominal circumference has some predictive value of disease beyond that of BMI, but 
not when BMI is over 35.  In this sample only one participant had an abdominal 
circumference under 35.  The target blood pressure range for people with diabetes is 
<130/80 mmHg (American Diabetes Association, 2003).  In this sample, the systolic 
goal was met by 31.9%, and the combined systolic/diastolic goal was met by 20.3% of 
individuals.   
American Diabetes Association standards of care indicate a target HbA1c of < 
7% for people with diabetes (American Diabetes Association, 2006), a goal met by 27% 
of the sample in which it was measured (n = 63).  Applying the cardiovascular risk level 
cutpoints for high sensitivity CRP (hs-CRP) test results (Pearson et al., 2003) to the 
sample data reveals that 28.2% fall in the range corresponding to low to average risk (< 
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1.0 mg/L to 3.0 mg/L), 40.8% are in the high risk range (> 3.0 mg/L to 10 mg/L), and  
31% have markedly high hs-CRP levels (> 10 mg/L).  Reference ranges for IL-6 could 
not be obtained. 
Table 1 
Demographic, biomedical, and psychological screening characteristics of the sample. 
 
     
Variable Frequency Percentage   
     
Sex     
     Female 62 87.3   
     Male   9 12.7   
Handedness     
     Right 67 94.4   
     Left   4   5.6   
     
     
 Mean S.D. Minimum Maximum 
     
Age (yrs) 67.06 5.00 60 80 
Education (yrs) 11.30 2.57 5 18 
     
Duration of diabetes (yrs) 14.84 9.28 1 47 
BMI 33.52 6.28 20.60 49.70 
Abdominal circumference (in) 46.57 5.32 34 59 
BP Systolic 137.67 21.83 100 220 
BP Diastolic 83.88 13.82 50 120 
HbA1c 8.17 1.97 5.60 14.60 
Interleukin-6 (pg/mL) 4.01 5.94 .58 40.00 
C-reactive protein (mg/L) 8.83 8.65 .08 46.41 
     
GDS 4.20 3.74 0 18 
3MS 87.07 6.15 71 100 
NAART 12.40 8.59 1 35 
Predicted WAIS-R           
Vocabulary Scaled Score 
 
8.38 
 
1.77 
 
5.25 
 
13 
     
 
 
According to the cutoff scores issued for the 30-item form of the Geriatric 
Depression Scale (GDS), normal range is 0 to 9, mild depression is 10 to 19, and 
severe depression is 20 to 30 (Yesavage et al., 1982).  By these criteria, 88.7% of 
participants in the sample fell in the normal range, and 11.3% fell in the mildly 
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depressed range.  Participants with a GDS score higher than 19 were excluded from the 
study.   
A cutoff score of 70 on the Modified Mini-Mental State Examination (3MS) was 
used to exclude participants from the study.  The 3MS scores of the sample ranged 
from 71 to 100 (M = 87.07; S.D. = 6.15).  3MS normative data for older adult African 
Americans is available (Brown, Schinka, Mortimer, & Graves, 2003) stratifying data by 
sex, age (60-71 or 73-84), and education (< 12, 12, or > 12 years).  Given that cell sizes 
were small at the two higher education ranges (as low as n = 2), data from the present 
sample were compared to normative data using only sex and age range.  Using these 
criteria, 91.6% of the sample (n = 65) had a 3MS score within 1.5 standard deviations of 
the age and sex appropriate normative data.  Only 4.2% of the sample (n = 3) scored 
more than 2 standard deviations above the published norms; those scores were above 
our cutoff, at 74 and 75.   
The North American Adult Reading Test (NAART) scores for the sample ranged 
from 1 to 35 (M = 12.40; S.D. = 8.59).  NAART performance is reportedly correlated with 
education and social class, but not with age, gender, or ethnicity (Strauss, Sherman, & 
Spreen, 2006).  Using NAART scores predicted based solely on age and education 
(Uttl, 2002) produced predicted scores that were an average of 19.45 raw score points 
higher than the observed scores from this sample of participants.  Thus, it may be that 
social class, which is not accounted for by this prediction equation, is a robust predictor 
of NAART performance in this sample.  Using an equation designed to predict WAIS-R 
Vocabulary subtest scores based on NAART score and years of education (Uttl, 2002) 
yielded scaled scores ranging from 5.25 to 13 (M = 8.38; S.D. = 1.77).  
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Descriptive statistics for neuropsychological outcome measures are shown in Table 2.  
Examination of the standardized scores reveals that mean scores for most 
neuropsychological tests fell in the average range or higher.  Exceptions included: 1) 
SDMT Written and SDMT Oral, which fell in the mildly impaired range, 2) CVLT-II Short 
Delay Free Recall, Long Delay Free Recall, and Long Delay Semantic Clustering, all of 
which were in the low average range, and 3) Grooved Pegboard, which was in the low 
average range for both hands.  Mean scores for a sample with such a wide range of 
ages and reading levels, however, may fail to adequately characterize performance 
levels.  To address this concern, Table 3 displays the percentage of participants falling 
into specific z-score ranges for the neuropsychological measures in the study purported 
to tap executive functions.  Examination of this table reveals that across tests, the 
percentage of participants falling more than one standard deviation below the norm 
ranged from 17.6 to 67.6 percent.  Based on the percentage of scores falling at least 
one standard deviation below the mean on this group of measures, participants in this 
sample appear to have performed best on Semantic Fluency (on which only 2.8% of the 
sample more than 1 S.D. below the mean score), followed by Phonemic Fluency (21.3% 
averaged across CFL and FAS), Stroop Color-Word (27.4%), Trail Making Test Part B  
(39.4%), SDMT Written (62.0 %), and SDMT Oral (67.6%).  Table 4 displays the 
percentage of participants falling into specific z-score ranges for relevant indices on the 
administered measures of verbal memory.  The distributions across the z-score range in 
this table indicates that the participants in this sample performed best on Logical 
Memory Immediate and Delayed Recall (both of which were associated with 11.3% of 
the sample scoring more than 1 S.D. below the norm), followed by scores from the 
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Table 2 
Descriptive statistics for neuropsychological outcome measures. 
 
       
 
Measure 
 
n 
 
Mean 
 
S.D. 
 Standardized  
Score 
 
S.D. 
       
Stroop Color-Word 69 21.06 10.61  9.57 3.45 
       
Trail Making Test Part B 71 209.28 87.44  8.37 3.45 
       
Semantic Fluency 71 14.65 4.17  -- -- 
     Animal Naming 36 14.83 3.29  11.12 2.54 
     Boys Names 35 14.46 4.96  -- -- 
       
Phonemic Fluency 71 26.38 11.08  -- -- 
     CFL           36 26.11 11.50  8.90 3.04 
     FAS 35 26.66 10.79  48.41 9.26 
       
Symbol Digit Modalities Test       
     Written 71 26.21 12.03  -1.39 1.34 
     Oral 71 30.80 12.62  -1.49 1.22 
       
WAIS-III Digit Span Total 70 12.31 3.13  46.49 6.93 
     Digits Forward 70 7.96 1.98  -- -- 
     Digits Backward 70 4.36 1.68  -- -- 
       
CVLT-II        
     Short Delay Free Recall 71 6.77 2.90  -.85 .94 
     Short Delay Semantic Clustering 71 .79 1.39  -.63 1.01 
     Long Delay Free Recall 71 8.61 3.17  -.96 .78 
     Long Delay Semantic Clustering 71 .96 1.40  -.72 .61 
       
WMS-III Logical Memory       
     Immediate Recall 71 32.45 9.85  53.31 12.36 
     Delayed Recall 71 18.39 7.12  56.58 12.96 
       
Grooved Pegboard       
     Dominant  70 130.40 55.42  42.26 8.95 
     Non-dominant 70 161.03 66.88  40.91 10.51 
       
Boston Naming Test 71 39.94 9.44  9.10 2.92 
       
Judgment of Line Orientation 15-item 70 7.91 3.53  -- -- 
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Table 3 
Percentage of participants within specified z-score ranges on executive function 
measures. 
 
        
Standard 
deviation  
from the mean 
 
 
Stroop 
CW 
 
 
Trails B 
Semantic 
Fluency - 
Animals  
Phonemic 
Fluency 
CFL  
Phonemic 
Fluency 
FAS  
 
SDMT  
Written 
 
SDMT  
Oral  
        
+3.0  to  +2.0 4.3 1.4 5.6 0.0 2.9 0.0 0.0 
+1.99  to  +1.0 8.7 11.3 19.4 11.1 5.9 2.8 1.4 
+.99  to  0 42.0 28.2 50.0 33.3 32.4 12.7 7.0 
–.01  to  –1.0 27.5 19.7 22.2 30.6 41.2 22.5 23.9 
–1.01  to  –2.0 14.5 35.2 2.8 22.2 17.6 26.8 36.6 
–2.01  to  –3.0 2.9 4.2 0.0 2.8 0.0 35.2 31.0 
        
        
 
Table 4 
Percentages of participants within specified z-score ranges on verbal memory 
measures. 
 
       
  CVLT-II  CVLT-II Logical Logical 
Standard 
deviation  
from the mean 
CVLT-II 
Short Delay 
Free Recall 
SDFR  
Semantic 
Clustering  
CVLT-II 
Long Delay 
Free Recall 
LDFR  
Semantic 
Clustering  
Memory 
Immediate 
Recall 
Memory  
Delayed 
Recall  
       
+3.0  to  +2.0 0.0 0.0 1.4 0.0 7.0 16.9 
+1.99  to  +1.0 7.0 4.2 1.4 4.2 28.2 28.2 
+.99  to  0 22.5 22.5 23.9 11.3 29.6 29.6 
–.01  to  –1.0 35.2 49.3 40.8 70.4 23.9 14.1 
–1.01  to  –2.0 29.6 23.9 25.4 14.1 8.5 8.5 
–2.01  to  –3.0 5.6 0.0 7.0 0.0 2.8 2.8 
       
       
       
 
CVLT-II:  Semantic Clustering – Long Delay Free Recall (14.1%), Semantic Clustering – 
Short Delay Free Recall (23.9%), Long Delay Free Recall (32.4%), and Short Delay 
Free Recall (35.2).   
Regression analyses   
Executive functions.  Results for the series of hierarchical multiple regression 
analyses examining the relationship between HbA1c, IL-6, CRP, and executive 
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functions are shown in Table 5.  Overall, the predictors accounted for a significant 
proportion of the variance in the Stroop Color-Word test, Trail Making Test Part B, and 
Semantic Fluency.  For both the Written and Oral versions of the Symbol Digit 
Modalities Test, the regression equation approached significance for HbA1c only.  The 
regression equation for Phonemic Fluency did not reach significance.        
For Stroop Color-Word, the full model accounted for a statistically significant 
proportion of the variation in the dependent measure, R2 = 30.2%, F(5,55) = 4.76, p < 
.01.  HbA1c accounted for no additional variance in the dependent measure above the 
covariates, ∆F(1,57) = .014, p < .91. The addition of the two inflammatory markers to 
the model accounted for an additional 8.0% of the variance, ∆F(2,55) = 3.17, p < .05. 
Among the inflammatory markers, only CRP made a significant unique contribution to 
the final model, t(1,55) = 2.46, p < .02, sr2 = 7.7%, indicating that higher levels of CRP 
were associated with higher numbers of correct responses on Stroop Color-Word.   
For Trail Making Test Part B, the full model accounted for a statistically 
significant portion of the variation in the dependent measure, R2 = 41.0%, F(5,56) = 
7.79, p < .01.  The addition of HbA1c to the equation accounted for an additional 6.3% 
of the variance above the covariates, ∆F(1,58) = 5.88, p < .02, indicating that higher 
levels of HbA1c were associated with longer times to complete the Trails B task.  IL-6 
and CRP accounted for an additional 2.9% of the variance in the dependent variable, 
although the change was not significant, ∆F(2,56) = 1.37, p = .26.   
 For Semantic Fluency, the full model accounted for a statistically significant 
portion of the variance in the dependent measure, R2 = 33.8%, F(5,56) = 5.72, p < .01.  
HbA1c accounted for no additional variance in the dependent measure above the  
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Table 5 
Hierarchical regression analyses of glycated hemoglobin, inflammatory markers, and 
cognitive measures tapping executive functions.  
 
 
 
Criterion Variables 
 
 
Step 
 
Predictor 
Variables 
 
Full Model 
∃ 
 
 
R2 
 
 
∆R2 
     
Stroop Color-Word 1  Age -.45**   
 NAART  .06 .22**  
 2 HbA1c -.01  .00 
 3 IL6 -.02   
 CRP  .29*  .08* 
     
     
Trail Making Test Part B 1  Age  .44**   
 NAART -.38 .32**  
 2 HbA1c  .26*  .06* 
 3 IL6  .07   
 CRP -.18  .03 
     
Semantic Fluency 1  Age -.46**   
 NAART  .20† .22**  
 2 HbA1c  .02  .00 
 3 IL6  .27*   
 CRP  .16  .12* 
     
Phonemic Fluency 1  Age -.25*   
 NAART  .51** .37**  
 2 HbA1c  .11  .01 
 3 IL6 -.05   
 CRP  .21†  .04 
     
Symbol Digit Modalities - Written 1  Age -.41**   
 NAART  .29* .23**  
 2 HbA1c -.21†  .04† 
 3 IL6 -.02   
 CRP  .21†  .04 
     
Symbol Digit Modalities - Oral 1  Age -.40**   
 NAART  .29* .24**  
 2 HbA1c -.21†  .04† 
 3 IL6 -.07   
 CRP  .20  .04 
      
†p < .10; *p < .05; **p < .01 
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covariates, ∆F(1,58) = .007, p < .94.  The addition of the two inflammatory markers to 
the model accounted for an additional 8.0% of the variance, ∆F (2,56) = 4.86, p < .05.  
Among the inflammatory markers, only IL-6 made a significant unique contribution to the 
final model, t(1,56) = 2.30, p < .03, sr2= 6.3%, indicating that higher levels of IL-6 were 
associated with greater numbers of correct semantic fluency responses.   
 For the Symbol Digit Modalities Test - Written version, the full model accounted 
for a statistically significant portion of the variance in the dependent measure, R2 = 
31.6%, F(5,56) = 5.18, p < .001.  The addition of HbA1c to the model accounted for an 
additional 4.0% of the variance above the covariates, a change that approached 
significance, ∆F(1,58) = 3.23, p = .08.  An additional 4.1% of the variance in the 
dependent variable was accounted for by adding IL-6 and CRP to the model, although 
the change was not significant, ∆F(2,56) = 1.69, p = .19.  Among the individual 
predictors, contributions to the final model that approached significance were made by 
HbA1c (as described above) and CRP, t(1,56) = 1.81, p = .08, sr2= 4.0%. 
 For the Symbol Digit Modalities Test – Oral version, the full model accounted for 
a statistically significant portion of the variance in the dependent measure, R2 = 31.3%, 
F(5,56) = 5.11, p < .001.  The addition of HbA1c to the model accounted for an 
additional 4.2% of the variance in the dependent variable above the covariates, a 
change that approached significance, ∆F(1,58) = 3.34, p = .07.  Adding IL-6 and CRP to 
the model accounted for an additional 3.5% of the variance, although this change was 
not significant, ∆F(2,56) = 1.42, p = .25.   
 For Phonemic Fluency, the full model accounted for a statistically significant 
portion of the variance in the dependent measure, R2 = 42.4%, F(5,56) = 8.26, p < .001.  
33 
 
The addition of HbA1c to the equation accounted for an additional 1.0% of the variance 
above the covariates, a change that was not statistically significant, ∆F(1,58) = .93, p = 
.34.  Adding IL-6 and CRP to the model accounted for an additional 4.1% of the 
variance, although this change was not statistically significant, ∆F(2,56) = 1.98, p = .15.  
Among the inflammatory markers, only CRP made a contribution to the final model that 
approached significance, t(1,56) = 1.98, p = .052, sr2 = 4.0%. 
 Verbal memory.  Results for the series of hierarchical multiple regression 
analyses examining the relationship between HbA1c, IL-6, CRP, and verbal memory are 
shown in Table 6.  Overall, the regression equations accounted for significant amounts 
of the variance in CVLT-II Semantic Clustering – Short Delay Free Recall, CVLT-2 Long 
Delay Free Recall, and Logical Memory – Delayed Recall.  For CVLT-II Short Delay 
Free Recall and Logical Memory – Immediate Recall, the variance accounted for by the 
regression equation approached significance.  The regression equation for CVLT-II 
Semantic Clustering – Long Delay Free Recall did not reach significance.     
 For CVLT-II Semantic Clustering – Short Delay Free Recall, the full model 
accounted for a statistically significant amount of the variance in the dependent 
measure, R2 = 20.2%, F(5,56) = 2.84, p < .02.  The addition of HbA1c to the model 
accounted for an additional 6.5% of the variance in the dependent variable above the 
covariates, ∆F(1,58) = 4.71, p < .03, indicating that higher levels of HbA1c were 
associated with reduced use of the semantic clustering strategy.  IL-6 and CRP 
accounted for no additional variance in the dependent measure, R2 = .20%, ∆F(1,58) = 
4.71, p < .03.   
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Table 6 
Hierarchical regression analyses of glycated hemoglobin, inflammatory markers, and 
verbal memory measures. 
 
 
 
Criterion Variables 
 
 
Step 
 
Predictor 
Variables 
 
Full Model 
∃ 
 
 
R2 
 
 
∆R2 
     
CVLT-II Short Delay Free Recall 1  Age -.14   
     NAART  .12  .02  
 2 HbA1c -.31*  .09* 
 3 IL6 -.22†   
 CRP  .20  .06 
     
     
CVLT-II Short Delay Free Recall  1  Age -.02   
    Semantic Clustering NAART  .37** .14*  
 2 HbA1c -.27*  .07* 
 3 IL6 -.04   
 CRP  .03  .00 
     
CVLT-II Long Delay Free Recall 1  Age -.25†   
     NAART  .15 .10*  
 2 HbA1c -.17  .03 
 3 IL6 -.21   
 CRP  .19  .06 
     
CVLT-II Long Delay Free Recall 1  Age  .02   
    Semantic Clustering NAART  .20 .04  
 2 HbA1c -.23†  .05† 
 3 IL6 -.17   
 CRP  .10  .03 
     
Logical Memory Immediate Recall 1  Age -.18   
 NAART  .33* .14**  
 2 HbA1c -.15  .02 
 3 IL6 -.09   
 CRP  .07  .01 
     
Logical Memory Delayed Recall 1  Age -.11   
 NAART  .30* .10*  
 2 HbA1c -.21  .04 
 3 IL6 -.17   
 CRP  .17  .04 
      
†p < .10; *p < .05; **p < .01 
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For CVLT-2 Long Delay Free Recall, the full model accounted for a statistically 
significant amount of the variance in the dependent measure, R2 = 17.8%, F(5,56) = 
2.43, p < .05.  Adding HbA1c to the model did not account for a statistically significant 
amount of the variance in the dependent variable above the covariates, ∆R2 = 2.5%, ∆F 
(1,58) = 1.62, p = .21.  The addition of IL-6 and CRP to the model also did not account  
for a significant amount of the variance in the dependent variable, ∆R2 = 5.7%, ∆F(2,56) 
= 1.95, p = .15.   
For Logical Memory – Delayed Recall, the full model accounted for a statistically 
significant amount of the variance in the dependent measure, R2 = 18.2%, F(5,56) = 
2.48, p < .04.  Adding HbA1c to the model did not account for a statistically significant 
amount of the variance in the dependent variable above the covariates, ∆R2 = 3.9%, 
∆F(1,58) = 2.62, p = .11.  The addition of IL-6 and CRP to the model also did not 
account for a significant amount of the variance in the dependent variable, ∆R2 = 4.1%, 
∆F (2,56) = 1.41, p = .25.   
For CVLT-II Short Delay Free Recall, the full model accounted for a portion of the 
variance in the dependent measure that approached significance, R2 = 17.3%, F(5,56) = 
2.34, p = .053.  Adding HbA1c to the model accounted for a statistically significant 
amount of the variance in the dependent variable above the covariates, ∆R2 = 8.8%, ∆F 
(1,58) = 5.76, p < .02, indicating that higher levels of HbA1c was associated with fewer 
words recalled.  The addition of IL-6 and CRP to the model did not account for a 
significant amount of the variance in the dependent variable, ∆R2 = 6.3%, ∆F(2,56) = 
2.12, p = .13.  Among the inflammatory markers, only IL-6 made a contribution to the 
final model that approached significance, t(1,56) = -1.71, p = .09, sr2 = 4.3%. 
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For Logical Memory – Immediate Recall, the full model accounted for a portion of 
the variance in the dependent measure that approached significance, R2 = 17.5%, 
F(5,56) = 2.37, p = .051.  Adding HbA1c to the model did not account for a statistically 
significant amount of the variance in the dependent variable above the covariates, ∆R2 = 
2.1%, ∆F(1,58) = 1.48, p = .23.  The addition of IL-6 and CRP to the model also did not 
account for a significant amount of the variance in the dependent variable, ∆R2 = 1.0%, 
∆F(2,56) = .33, p = .72.             
For CVLT-II Semantic Clustering – Long Delay Free Recall, the full model did not 
account for a statistically significant amount of the variance in the dependent variable, 
R2 = 11.5%, F(5,56) = 1.45, p = .22.  The addition of HbA1c to the model accounted for 
a portion of the variance in the dependent variable above the covariates that 
approached significance, ∆R2 = 4.9%, ∆F (1,58) = 1.48, p = .08.  Adding IL-6 and CRP 
to the equation did not add significantly to the variance accounted for in the dependent 
variable, ∆R2 = 2.9%, ∆F(2,56) = .92, p = .41. 
Attention, language, visuospatial judgment, and fine motor dexterity.  Results for 
the series of hierarchical multiple regression analyses examining the relationship 
between HbA1c, IL-6, CRP, and the array of neuropsychological measures measuring 
attention, language, visuospatial judgment, and fine motor dexterity are shown in Table 
7.  Overall, the regression equations accounted for significant amounts of the 
variance in Digits Forward, Digits Backward, Boston Naming, and Grooved Pegboard 
for both Dominant and Non-dominant hands.  The regression equation for Judgment of 
Line Orientation did not reach significance.  
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Table 7 
Hierarchical regression analyses of glycated hemoglobin, inflammatory markers, and 
cognitive function measures. 
 
 
 
Criterion Variables 
 
 
Step 
 
Predictor 
Variables 
 
Full Model 
∃ 
 
 
R2 
 
 
∆R2 
     
Digits Forward 1  Age -.30*   
 NAART  .30 .19**  
 2 HbA1c -.06  .00 
 3 IL6  .07   
 CRP  .03  .01 
     
Digits Backward 1  Age -.21†   
 NAART  .49** .32**  
 2 HbA1c -.01  .00 
 3 IL6 -.04   
 CRP  .06  .00 
     
Boston Naming 1  Age -.19   
     NAART  .46** .25**  
 2 HbA1c -.11  .01 
 3 IL6 -.07   
 CRP  .19  .03 
     
Judgment of Line Orientation  1  Age -.18   
 NAART  .20 .08†  
 2 HbA1c -.16  .02 
 3 IL6 -.16   
 CRP  .07  .02 
     
Grooved Pegboard - Dominant 1  Age  .32*   
 NAART -.04 .13**  
 2 HbA1c  .15  .02 
 3 IL6  .31*   
 CRP -.23†  .11* 
     
Grooved Pegboard – Non-dominant 1  Age -.11   
 NAART  .30* .16**  
 2 HbA1c -.21  .06* 
 3 IL6 -.17   
 CRP  .17  .08* 
      
†p < .10; *p < .05; **p < .01 
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For Digits Forward, the full model accounted for a statistically significant amount 
of the variance in the dependent measure, R2 = 20.1%, F(5,56) = 2.82, p < .02.  No 
additional variance above the covariates was accounted for by the addition of HBA1c, 
∆R2 = .30%, ∆F(1,58) = .20, p = .65, or the inflammatory markers IL-6 and CRP, ∆R2 = 
.50%, ∆F(2,56) = .17, p = .84. 
For Digits Backward, the full model accounted for a statistically significant 
amount of the variance in the dependent measure, R2 = 32.3%, F(5,56) = 5.35, p < 
.001.  No additional variance above the covariates was accounted for by the addition of 
HBA1c, ∆F(1,58) = .003, p = .96, or the inflammatory markers IL-6 and CRP, ∆R2 = 
.40%, ∆F(2,56) = .15, p = .86. 
For Boston Naming, the full model accounted for a statistically significant amount 
of the variance in the dependent measure, R2 = 29.8%, F(5,56) = 4.74, p < .001.  No 
additional statistically significant variance above the covariates was accounted for by 
the addition of HBA1c, ∆R2 = 1.2%, ∆F(1,58) = .91, p = .34, or the inflammatory markers 
IL-6 and CRP, ∆R2 = 3.2%, ∆F(2,56) = 1.29, p = .28. 
For Grooved Pegboard – Dominant Hand, the full model accounted for a 
statistically significant amount of the variance in the dependent measure, R2 = 25.5%, 
F(5,56) = 3.83, p < .005.  The additional variance above the covariates accounted for by 
the addition of HbA1c was not statistically significant, ∆R2 = 2.0%, ∆F (1,58) = 1.35, p = 
.25.  Adding IL-6 and CRP to the equation accounted for a statistically significant 
amount of variance in the dependent variable above that contributed by the covariates, 
∆R2 = 10.7%, ∆F(2,56) = 4.02, p < .02.  Among the inflammatory markers, IL-6 made a 
unique and statistically significant contribution to the variance in the final model, t(1,56) 
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= 2.54, p < .01, sr2 = 8.6%, indicating that higher levels of IL-6 were associated with 
longer time to completion on Grooved Pegboard – Dominant.  The unique contribution 
of CRP to the final model approached significance, t(1,56) = -1.91, p = .062, sr2 = 4.8%. 
For Grooved Pegboard – Non-dominant Hand, the full model accounted for a 
statistically significant amount of the variance in the dependent measure, R2 = 29.9%, 
F(5,56) = 4.78, p < .001.  HbA1c accounted for 5.9% of additional variance in the 
dependent measure above the covariates, ∆F(1,58) = 4.39, p < .04.  Adding IL-6 and 
CRP to the model accounted for an additional 8.2% of the variance in the dependent 
variable, ∆F(2,56) = 3.27, p < .045.  Among the inflammatory markers, only IL-6 made a 
unique and statistically significant contribution to the variance in the model, t(1,56) = 
2.39, p < .02, sr2 = 3.0%, indicating that higher levels of IL-6 were associated with 
longer time to completion on Grooved Pegboard – Non-dominant. 
For Judgment of Line Orientation, the full model did not account for a statistically 
significant amount of the variance in the dependent variable, R2 = 12.9%, F(5,56) = 
1.66, p = .16.  No additional statistically significant variance above the covariates was 
accounted for by the addition of HBA1c, ∆R2 = 2.3%, ∆F(1,58) = 1.48, p = .23, or the 
inflammatory markers IL-6 and CRP, ∆R2 = 2.3%, ∆F(2,56) = .724, p = .49. 
Further exploratory analyses 
The following analyses were conducted in order to determine whether any 
additional information could be obtained that could aid in the interpretation the results 
that have been presented. These analyses must be considered exploratory, however, 
because removing cases or adding variables to these analyses results in a reduction in 
the power to detect effects. The previous analyses employed six variables and thus had 
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already reached the power limits for this design and sample size (Field, 2005).  
Nonetheless, the following analyses were conducted in order to determine whether any 
effects were present that were large enough to be detected under these limited 
circumstances.  
Investigation of CRP effects.  In the original analyses, the results indicated that 
higher levels of CRP were associated with improved cognitive performance.  In order to 
further examine the direction of the relationship between CRP and cognitive 
performance, the cases with the highest levels of CRP (> 10mg/L; n = 22) were 
removed and the original analyses were performed again.  This modification of the 
sample yielded a change in the direction of the relationship between CRP and cognition 
for all relevant criterion variables, such that higher levels of CRP were associated with 
worse performance on Stroop Color-Word, Semantic Fluency, Phonemic Fluency, and 
Symbol Digit Modalities – Written version.  This result is suggestive of a U-shaped 
function in which very high levels of CRP (< 10 mg/L) are associated with improved 
performance on the cognitive measures tapping executive functions, whereas for those 
patients with levels of CRP falling in the low to high risk range, higher levels of CRP are 
associated with poorer executive function performance.   
Relationship with other covariates: Depression and duration of diabetes.  In order 
to determine whether depression accounted for any of the variance in the criterion 
variables, all of the original regression analyses were re-run with GDS score entered as 
a covariate at the second step.  GDS score did not contribute significantly to the 
variance in the model either at the second step or in the final model for any of the 
measures of executive function or verbal memory, nor did it change any of the patterns 
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of effects already reported.  Among the remaining neuropsychological criterion 
variables, the addition of GDS was significant only for Digits Backward.  Specifically, the 
full model accounted for 41.1% of the variance in the dependent variable, F(6,55) = 
6.39, p < .001, as compared with 32.3% for the same model without GDS included.  
Adding GDS to the model accounted for an additional 8.2% of variance above that 
contributed by the covariates, ∆F(1,58) = 7.98, p < .006.  GDS made a unique and 
statistically significant contribution to the variance in the full model, t(1,55) = 2.86, p < 
.005, sr2 = 3.0%, indicating that higher scores on the GDS were associated with 
improved Digits Backward performance. 
In order to determine whether duration of diabetes accounted for any of the 
variance in the criterion variables, all of the original regression analyses were re-run 
with duration of diabetes entered as a covariate at the second step.  The rationale for 
entering duration of diabetes before HbA1c is that duration might be associated with 
long-term neurological changes (Awad et al., 2004), whereas HbA1c may have a 
relatively transient effect on cognition in comparison.  Duration of diabetes did not 
contribute significantly to the variance in the dependent variable for any of the measures 
of executive function.  Among measures of verbal memory, duration of diabetes made 
significant contributions to the models for CVLT-II Short Delay Free Recall and Logical 
Memory Immediate Recall.  Duration of diabetes also contributed significantly to the 
variance in the model for the Boston Naming Test.   
For CVLT-II Short Delay Free Recall, the full model accounted for 21.9% of the 
variance in the dependent variable, F(6,55) = 2.58, p < .03, an increase of 4.6% over 
the same model without duration of diagnosis, and a shift to statistical significance.  The 
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addition of duration of diabetes to the model accounted for an additional 9.5% of the 
variance in the dependent variable above the covariates, ∆F(1,58) = 4.26, p < .01.  
Whereas HbA1c was statistically significant and IL-6 approached significance in the 
previous model, those effects were eliminated with the addition of duration of diabetes.             
For Logical Memory Immediate Recall, the full model accounted for 24.0% of the 
variance in the dependent variable F(6,55) = 2.90, p < .02, an increase of 6.5% over the 
same model without duration of diabetes.  The addition of duration of diabetes to the 
model accounted for an additional 8.1% of the variance in the dependent variable above 
the covariates, ∆F(1,58) = 6.05, p < .02.  As in the model without duration of diabetes, 
however, no additional variance above the covariates was contributed by adding 
HbA1c, IL-6 and CRP to the model. 
For the Boston Naming Test, with duration of diabetes included, the full model 
accounted for 33.9% of the variance in the dependent variable, F(6,55) = 4.70, p < .001.  
The addition of duration of diabetes to the model accounted for an additional 5.3% of 
the variance in the dependent variable above the covariates, ∆F(1,58) = 8.57, p < .001.  
As in the previous model without duration of diabetes, the addition of HbA1c, IL-6 and 
CRP to the model did not account for a statistically significant amount of variance in the 
dependent variable above the covariates.  In the final model, the contribution to the 
model made by duration of diagnosis only approached significance, t(1,55) = -1.86, p = 
.07, sr2 = 4.1%. 
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CHAPTER 4:  DISCUSSION 
The elderly African Americans with type 2 diabetes who served as participants in 
this study generally performed in the average range on neuropsychological measures.  
There were some exceptions, though.  Participants were mildly impaired on both the 
written and oral versions of the Symbol Digit Modalities test, demonstrated low average 
performance on three of the CVLT-II scores (Short and Long Delay Free Recall, and 
Long Delay Semantic Clustering), and low average performance on Grooved Pegboard 
for both hands.  Thus, these results provide partial support for the hypothesis that these 
participants would be impaired in some aspects of executive function and on measures 
of verbal memory that require intact executive functions for adequate performance.  
Mean scores for all other executive function measures were in the average range, 
however, which is inconsistent with that hypothesis.  The low average performances on 
the CVLT-II are consistent with the hypothesis, but this low average range was not 
significantly different from average.   
The findings of the present study are consistent with the hypothesis that chronic 
hyperglycemia would be inversely related to performance on measures of executive 
function and verbal memory that tap executive functions, but not to other 
neuropsychological measures.  Higher HbA1c scores were significantly associated with 
poorer performance on Trail Making Test Part B, CVLT-II Short Delay Free Recall, and 
CVLT-II Semantic Clustering – Short Delay Free Recall, and approached significance in 
predicting poorer performance on Symbol Digit Modalities Test – Written and Oral 
versions, and CVLT-II Semantic Clustering – Long Delay Free Recall.   
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The observed association between higher HbA1c and impaired performance on a 
word list learning task is consistent with previous findings (Gradman et al., 1993; 
Jagusch, Cramon, Renner, & Hepp, 1992; Perlmuter et al., 1984; Reaven et al., 1990), 
and extends the previous findings by demonstrating a similar effect in an elderly African 
American sample.  A few studies have reported no significant relationship between 
HbA1c and word list learning.  For example, Lowe and colleagues (Lowe et al., 1994) 
employed another widely used word list learning test, the Rey Auditory Verbal Learning 
Test (RAVLT), and found no group differences between diabetics and controls.  Their 
sample consisted of Native Americans, however, and was younger, ranging in age from 
45 to 75 years old.  Zaslavsky and colleagues (Zaslavsky, Gross, Chaves, & Machado, 
1995) employed a word list learning task that, similar to the CVLT-II, involved the five 
auditory presentations of a word list.  Unlike the CVLT-II, however, the task used by 
Zaslavsky and colleagues entailed free recall trials occurring only after the first and fifth 
list presentations, and then again after a 15-minute interval.  In contrast, the CVLT-II 
consists of free recall trials occurring following each of the five list presentations, and 
then again after a brief delay and a longer, 20-minute interval.  Thus, the encoding 
process for the word list-learning task used by Zaslavsky and colleagues may be 
qualitatively different that that engaged in during CVLT-II.  Specifically, the CVLT-II 
offers many more opportunities to reinforce the learning of the list words than does the 
other task.  No other information was provided about the types of words in the lists used 
by Zaslavsky and colleagues or their semantic relationships, which also may have 
accounted for some of the difference in the outcomes.    
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In the present study chronic hyperglycemia and inflammation were not 
significantly associated with immediate or delayed recall performance on a paragraph 
recall task.  This result is inconsistent with those of a previous study in which 
experimentally-induced acute hyperglycemia was associated with a relative decline in 
recall on an auditory-verbal paragraph recall task (Greenwood et al., 2003).  There may 
be differences in the relative influence on cognitive function of acute versus chronic 
hyperglycemia, however.  It may be that those individuals in the present study with 
higher acute glucose levels performed more poorly on this task, but this could not be 
determined because acute glucose levels were not measured.  The present results do 
support a relationship between duration of diagnosis (i.e., the effects of long-term 
chronic hyperglycemia) and verbal learning and memory decrements, however.  
Specifically, longer duration of diabetes diagnosis was associated with poorer 
immediate recall performance both on a paragraph recall task and on a verbal word list-
learning task.  This result is similar to those in a previous study (Elias et al., 1997) in 
which impaired immediate and delayed word list-learning were related to duration of 
diabetes diagnosis.  Further, in the present study there was a trend toward an 
association between longer duration of diagnosis and poorer performance on a 
confrontation picture-naming task that relies heavily upon intact semantic retrieval 
abilities.  These deficits are similar to the classic pattern of cognitive impairment 
observed in dementia of the Alzheimer’s type, which involves rapid forgetting and 
impaired semantic retrieval (Wicklund, Johnson, Rademaker, Weitner, & Weintraub, 
2006).  It is unclear whether diabetes increases the risk of Alzheimer’s disease 
(Arvanitakis, Wilson, Bienias, Evans, & Bennett, 2004) or not (Akomolafe et al., 2006), 
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but the present results suggest that those with a longer duration of diagnosis are more 
likely to manifest a pattern of cognitive performance that is similar to that found among 
individuals with dementia of the Alzheimer’s type.   
The present finding of the association between higher HbA1c and impaired Trails 
B performance is consistent with the results of one previous study (Reaven, 1991) in 
which HbA1c was inversely related to Trails B performance in both a group of 29 elderly 
type 2 diabetes patients, and in the group of 30 demographically similar, healthy 
controls.  This finding is inconsistent with the results of several other studies, however.  
For example, in one study, 50 Caucasian and African American adults with type 2 
diabetes and 50 demographically similar, healthy controls failed to differ on Trails B 
after controlling for age, sex, race, and estimated IQ (Ryan & Geckle, 2000a).  Notably, 
however, the participants were mostly middle-aged, ranging in age from 34 to 65 (M = 
50.8).  In another study, elderly type 2 diabetics and controls did not differ on Trails B 
(Helkala, Niskanen, Viinamaki, Partanen, & Uusitupa, 1995).  The group sizes were 
relatively small, however, (ns = 20 and 22, respectively), and they used means 
comparisons instead of regressions, and thus, could not control for the effects of age 
and education.  In sum, it may be that Trails B performance varies with HbA1c levels in 
elderly adults, but sufficiently large sample sizes and appropriate statistical methods are 
required in order to observe this effect.      
  This is the first study to examine the effects of inflammation and chronic 
hyperglycemia in a group comprised solely of adults with type 2 diabetes.  Zero-order 
correlations between glycated hemoglobin and inflammation indicated that HbA1c was 
not related to either IL-6 (r = -.08; p = .53) or CRP (r = .00; p = .99).  This result may 
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have been an artifact of the study methods, however, given that in most cases HbA1c 
and the inflammatory markers were measured on different days.  Thus, it is possible 
(although unclear from the literature) that HbA1c is typically more highly related with the 
inflammatory markers.  Notably, the inflammatory markers were also not highly 
correlated with each other (r = .26, p < .04).  The fact that these predictors had so little 
statistical relationship to each other suggested that different patterns of effects for 
HbA1c and each of the inflammatory markers might be expected.  Indeed, there was 
very little overlap in the effects of the three predictor variables.  Higher IL-6 significantly 
predicted slower completion times on Grooved Pegboard – Dominant hand, but also 
was associated with a greater number of correct responses on Semantic Fluency; IL-6 
approached significance in predicting poorer performance on CVLT-II Short Delay Free 
Recall.  CRP was unique among the predictor variables in this study in that, contrary to 
the study hypothesis, higher CRP levels were associated with improved cognitive 
performance.  Specifically, higher CRP was significantly associated with better 
performance on Stroop Color-Word, and approached significance in predicting better 
performance on Phonemic Fluency, Symbol Digit Modalities – Written version, and 
Grooved Pegboard – Dominant hand.  This finding is inconsistent with the majority of 
the literature, which tends to show an inverse relationship between CRP and cognition 
(Engelhart et al., 2004; Schmidt et al., 2002; Teunissen et al., 2003; Yaffe et al., 2004; 
Yaffe et al., 2003).  One study, however, showed that in older adults with the APOE4 
allele, higher CRP was associated with lower rates of dementia and cognitive 
impairment without dementia, whereas in a control group without the APOE4 allele, 
higher CRP was associated with increased rates of dementia and cognitive impairment 
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without dementia (Haan, Aiello, West, & Jagust, 2007).  Further, in those without the 
APOE4 allele, CRP was significantly lower.  They interpreted the results as suggesting 
that in those with APOE4, high CRP may be a marker of better immune function, 
leading to reduced rates of dementia and Alzheimer’s disease.  In the present study, an 
exploratory analysis was conducted in which the cases with the highest levels of CRP 
were removed from the analyses.  Results showed that with the CRP levels in the 
analysis reduced to the range of low to high risk only, the direction of the relationship 
reversed between CRP and several of the criterion variables--particularly executive 
measures--such that CRP was inversely related to cognitive performance.  This result 
suggests that it was primarily those with very high CRP (> 10 mg/L) driving the effect of 
higher CRP being related to improved performance on cognitive measures.  APOE4 
was not assessed in these participants (n = 22), but it seems unlikely that all of the 
participants with the highest levels of CRP in this study had the APOE4 allele.  It may 
be, however, that higher CRP is associated with better cognitive functioning (possibly 
via improved immune functioning) in some groups, including those with the APOE4 
allele, and may be related to other as yet unknown factors, as well.   
While the majority of studies of diabetes and cognition have used predominantly 
or solely Caucasian samples, and a few had mixed-race samples (Ryan & Geckle, 
2000a), this is the first study to examine the relationship between HbA1c and cognition 
in a group of older adult African Americans with type 2 diabetes.  One study examining 
the relationships of HbA1c, blood pressure, and several other indicators of 
cardiovascular risk in middle aged and older adult (43-82 years) African Americans 
found that HbA1c was significantly related to better performance on Digits Forward, and 
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marginally associated with better performance on an executive function screening 
measure (Izquierdo-Porrera & Waldstein, 2002).  This study differs from the present 
study in several important ways, however, including the inclusion of middle aged 
participants, a small sample size (n = 43), and the fact that only 19% of their sample 
was diabetic.  Another study employing a small sample (n = 43) of African American 
adults found that a summary cardiovascular risk score was associated with increased 
risk of impaired performance on a set of executive function tasks, but not on 
visuospatial or memory tests (Pugh et al., 2003).  The executive function tasks included 
Trails B, Phonemic and Semantic Fluency, and Letter-Number Sequencing, while the 
memory tests included Logical Memory Immediate and Delayed Recall, and a visual 
memory task.  Although only 12% (n = 5) of the sample had a self-reported diabetes 
diagnosis, and the sample size was small, the findings of this study are consistent with 
the present results, and provide additional evidence for the finding that in elderly African 
Americans, cardiovascular risk factors are associated with impairments in executive 
functions, but not contextual verbal memory.   
Consistent with the study predictions, levels of HbA1c, IL-6, and CRP were not 
significantly associated with performance on measures of visuospatial judgment, 
language, simple auditory attention, or fine motor dexterity.  Contrary to that prediction, 
however, significant effects of the predictor variables were observed for Grooved 
Pegboard, both for the Dominant and for the Non-dominant hand.   The Grooved 
Pegboard task has rarely been used in studies of older adults with type 2 diabetes, but 
there is a small amount of evidence indicating that this population may have difficulty 
with this task.  For example, psychomotor slowing among middle aged diabetics has 
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been reported, results that were based in part on impaired Grooved Pegboard 
performance (Ryan & Geckle, 2000a).  It was also demonstrated that improving glucose 
regulation in a small group of elderly diabetics (n = 16) yielded improved performance 
on a number of neuropsychological measures, including the Grooved Pegboard test 
(Meneilly, Cheung, Tessier, Yakura, & Tuokko, 1993).  The results of the present study 
add to this small group of evidence suggestive of psychomotor slowing and/or reduced 
fine motor dexterity in older adults with type 2 diabetes.   
Digits Backward performance was not significantly impaired in this sample of 
individuals with diabetes, nor was it significantly predicted by chronic hyperglycemia or 
inflammation.  Although Digits Backward, as a working memory test, is often grouped 
with measures of executive function, it was not predicted to be impaired in this study 
because it was not impaired in previous studies of cognitive function in older adults with 
diabetes (Atiea, Moses, & Sinclair, 1995; Mooradian, Perryman, Fitten, Kavonian, & 
Morley, 1988; Perlmuter, Tun, Sizer, McGlinchey, & Nathan, 1987; Reaven et al., 1990; 
U'Ren et al., 1990) or who were deemed to be at high risk for diabetes (Vanhanen et al., 
1997).  The failure to observe a significant effect of diabetes on this working memory 
task may be attributable both to the difficulty of the task for older adults, and a restriction 
in the range of scores for older adults.  In other words, this task may be very difficult for 
all adults in that age range.  Thus, whether the comparison is made with healthy 
controls or with published normative data, the performance of older adults with diabetes 
appears to fall within the average range.  Further, if most older adults correctly recall 
very few digit strings on Digits Backward, the range of scores would be restricted, 
reducing the correlation with other variables.  A large sample size can increase the 
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chances of detecting a small effect.  The previous studies with null findings for Digits 
Backward had diabetic sample sizes ranging from 29 to 43 participants.  The fact that 
no significant effects were detected for Digits Backward even with the larger sample in 
the present study provides more evidence for the lack of association between 
hyperglycemia and performance on this task.  The present results also extend those 
results to suggest a lack of association between Digit Span performance and 
inflammation, as represented by levels of IL-6 and CRP.  Notably, Digits Backward 
performance was predicted by one variable in this study.  Specifically, those with higher 
scores on the depression screening measure (GDS) performed significantly better on 
Digits Backward than those with lower GDS scores.  Given that depression is a well-
known predictor of impaired cognitive functioning, particularly on measures such as 
Digits Backward that require intact attentional and working memory abilities, this result 
was unexpected.  It should be noted however, that the majority of participants’ GDS 
scores fell in the non-depressed range, and those with the highest scores fell in the 
mildly depressed range (n = 5).  Given that there were no moderately or severely 
depressed individuals included in the sample, it may be that the mildly elevated GDS 
scores and the higher Digits Backward scores were both reflective of effort.  
Specifically, it is possible that those participants who were willing to admit to more 
symptoms associated with depression may also have been more cooperative with the 
testing process overall, and may have devoted more effort to testing, earning higher 
scores on the challenging Digits Backward task.   
  There are several weaknesses in the present study that limit the generalizability 
of the results.  First, the sample size was relatively small.  Unfortunately, relatively small 
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sample sizes characterize much of the literature examining the relationships between 
diabetes and cognition.  A larger sample would have allowed for the detection of any 
smaller effects that may have been present.  Further, the relatively low number of 
participants limited the number of variables that could be assessed in each analysis.  
Thus, while some of the covariates that were measured may have accounted for a 
statistically significant amount of additional variance in a larger sample, given the small 
sample size there was not enough power to detect any additional effects related to 
these additional variables.  Having more participants would allow for the testing of more 
complex models of the potential relationships between variables.  While there were a 
number of variables that were measured but not included in the study because of the 
small sample size, there were still other variables that were not measured that may 
have been informative.  For instance, it would likely have been useful to have measures 
of acute glucose levels, blood lipid levels, and current medications.   
Another weakness of this study is the lack of a control group.  Having a control 
group would have allowed for the direct comparison of scores on cognitive measures 
with a healthy, age- and education-matched control group rather than relying upon 
published normative data to interpret test results.  In addition, having a control group 
would have allowed for the examination of whether or not the observed pattern of 
relationships among IL-6, CRP, and cognition would also hold for individuals without 
type 2 diabetes.  Unfortunately, despite employing a number of methods in an attempt 
to recruit controls, only two control participants were tested.  Diabetic participants were 
recruited via phone calls to individuals listed in the patient database in the diabetes 
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clinic.  Perhaps obtaining access to a list of patients from a preventative medicine clinic 
would yield more fruitful recruiting results for controls.   
Another weakness of the study was the small number of men in the sample.  
Reportedly, the research recruitment of African American males can be especially 
problematic (M. Norman, personal communication, May 25, 2007).  Greater wariness 
about participating in research among African Americans has been documented in a 
study (Corbie-Smith, Thomas, & St. George, 2002) in which results indicated that 
distrust of research was significantly higher among males.  Suggestions for increasing 
research recruitment success in the African American community included engaging in 
ongoing community involvement even when research recruitment is not occurring.   
In summary, this research advances our understanding of the ways in which type 
2 diabetes impairs cognition in older adults, and the potential mechanisms underlying 
such cognitive deficits.  While most studies examining this topic have focused on older 
adult Caucasians, this study was the first specifically aimed at examining cognitive 
functioning in older African-Americans with type 2 diabetes.  Further, this is the first 
study to examine the impact of both chronic hyperglycemia and inflammation on 
cognitive functioning in a group of older adults with type 2 diabetes.  Results showed 
that, on average, cognitive functioning was in the average range in this sample of older 
African American adults with type 2 diabetes.  A certain proportion of the group, 
however, displayed significant cognitive deficits and, as predicted, those deficits were 
predominantly in executive functioning rather than in the domain of memory.  In future 
research it will be important to establish which variables best account for the 
predominantly executive cognitive deficits among certain older adults with type 2 
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diabetes.  Based on the pattern of effects observed in the present study, it appears that 
chronic and acute glucose levels would be important predictors, and that using a larger 
sample size would allow for the detection of smaller effect sizes on the various 
executive functioning measures.  This research is important because extensive 
evidence indicates that cognitive impairment limits the capacity to self-manage medical 
problems and follow medical recommendations in various medical populations.  In order 
to adhere to a diabetes management plan, a patient must not only remember medical 
instructions, but must also have the cognitive capacity necessary to implement them 
correctly and consistently (Park & Kidder, 1996).  Results of one study suggest that 
executive functioning and working memory are critical predictors of medication 
adherence.  Specifically, a composite of executive function and working memory tasks 
was the only significant predictor of medication adherence in a group of 95 elderly 
adults when entered into a regression equation with several other predictors, including 
age, mental status exam score, a composite memory test score, education, illness 
severity, financial well-being, and depression (Insel, Morrow, Brewer, & Figueredo, 
2006).  Given that a portion of older adults with type 2 diabetes exhibit executive 
function deficits, future research should investigate whether the executive deficits 
observed in some older adults with type 2 diabetes are also predictive of poor 
medication adherence.   
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